Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8+T cell function and its impact against pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is currently difficult to treat, even when therapies are combined with immune checkpoint blockade (ICB). A novel strategy for immunotherapy would be to maximize the therapeutic potential of oncolytic viruses (OVs), which have been proven to engage the regulati...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Wei, Linqing Tian, Xiaoyan Zheng, Lei Zhong, Yuan Chen, Hui Dong, Guibing Zhang, Shibing Wang, Xiangmin Tong
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:OncoImmunology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2024.2322173
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846142179156688896
author Wei Wei
Linqing Tian
Xiaoyan Zheng
Lei Zhong
Yuan Chen
Hui Dong
Guibing Zhang
Shibing Wang
Xiangmin Tong
author_facet Wei Wei
Linqing Tian
Xiaoyan Zheng
Lei Zhong
Yuan Chen
Hui Dong
Guibing Zhang
Shibing Wang
Xiangmin Tong
author_sort Wei Wei
collection DOAJ
description Pancreatic ductal adenocarcinoma (PDAC) is currently difficult to treat, even when therapies are combined with immune checkpoint blockade (ICB). A novel strategy for immunotherapy would be to maximize the therapeutic potential of oncolytic viruses (OVs), which have been proven to engage the regulation of tumor microenvironment (TME) and cause-specific T-cell responses. To boost tumor sensitivity to ICB therapy, this study aimed to investigate how glutathione peroxide 4 (GPX4)-loaded OVs affect CD8+ T cells and repair the immunosuppressive environment. Here, we successfully constructed a novel recombinant oncolytic vaccinia virus (OVV) encoding the mouse GPX4 gene. We found the OVV-GPX4 effectively replicated in tumor cells and prompted the expression of GPX4 in T cells. Our research indicated that OVV-GPX4 could reshape the TME, rectify the depletion of CD8+T cells, and enhance the antitumor effects of ICB therapy.
format Article
id doaj-art-2f9bb22f793f46ba9af769c26eb24f3d
institution Kabale University
issn 2162-402X
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series OncoImmunology
spelling doaj-art-2f9bb22f793f46ba9af769c26eb24f3d2024-12-03T13:49:35ZengTaylor & Francis GroupOncoImmunology2162-402X2024-12-0113110.1080/2162402X.2024.2322173Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8+T cell function and its impact against pancreatic ductal adenocarcinomaWei Wei0Linqing Tian1Xiaoyan Zheng2Lei Zhong3Yuan Chen4Hui Dong5Guibing Zhang6Shibing Wang7Xiangmin Tong8Zhejiang Provincial People’s Hospital Affiliated People’s Hospital, Hangzhou Medical College, Postgraduate Training Base of Jinzhou Medical University, Hangzhou, Zhejiang, People’s Republic of ChinaDepartment of Clinical Medicine, Bengbu Medical College, Bengbu, ChinaDepartment of Laboratory Medicine, Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, ChinaDepartment of Laboratory Medicine, Tongxiang Traditional Chinese Medicine Hospital, Tongxiang, Zhejiang, ChinaDepartment of Pathology, Zhejiang Provincial People’s Hospital Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, ChinaDepartment of Stomatology, Punan Hospital of Pudong New District, Shanghai, ChinaDepartment of Hematology, Hangzhou Fuyang First People’s Hospital, Hangzhou, Zhejiang, People’s Republic of ChinaCancer Center, Department of Pathology, Zhejiang Provincial People’s Hospital Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, ChinaKey Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Department of Clinical Research Center, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaPancreatic ductal adenocarcinoma (PDAC) is currently difficult to treat, even when therapies are combined with immune checkpoint blockade (ICB). A novel strategy for immunotherapy would be to maximize the therapeutic potential of oncolytic viruses (OVs), which have been proven to engage the regulation of tumor microenvironment (TME) and cause-specific T-cell responses. To boost tumor sensitivity to ICB therapy, this study aimed to investigate how glutathione peroxide 4 (GPX4)-loaded OVs affect CD8+ T cells and repair the immunosuppressive environment. Here, we successfully constructed a novel recombinant oncolytic vaccinia virus (OVV) encoding the mouse GPX4 gene. We found the OVV-GPX4 effectively replicated in tumor cells and prompted the expression of GPX4 in T cells. Our research indicated that OVV-GPX4 could reshape the TME, rectify the depletion of CD8+T cells, and enhance the antitumor effects of ICB therapy.https://www.tandfonline.com/doi/10.1080/2162402X.2024.2322173Glutathione peroxide 4oncolytic vaccinia viruspancreatic ductal adenocarcinomatumor microenvironment
spellingShingle Wei Wei
Linqing Tian
Xiaoyan Zheng
Lei Zhong
Yuan Chen
Hui Dong
Guibing Zhang
Shibing Wang
Xiangmin Tong
Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8+T cell function and its impact against pancreatic ductal adenocarcinoma
OncoImmunology
Glutathione peroxide 4
oncolytic vaccinia virus
pancreatic ductal adenocarcinoma
tumor microenvironment
title Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8+T cell function and its impact against pancreatic ductal adenocarcinoma
title_full Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8+T cell function and its impact against pancreatic ductal adenocarcinoma
title_fullStr Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8+T cell function and its impact against pancreatic ductal adenocarcinoma
title_full_unstemmed Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8+T cell function and its impact against pancreatic ductal adenocarcinoma
title_short Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8+T cell function and its impact against pancreatic ductal adenocarcinoma
title_sort expression of gpx4 by oncolytic vaccinia virus can significantly enhance cd8 t cell function and its impact against pancreatic ductal adenocarcinoma
topic Glutathione peroxide 4
oncolytic vaccinia virus
pancreatic ductal adenocarcinoma
tumor microenvironment
url https://www.tandfonline.com/doi/10.1080/2162402X.2024.2322173
work_keys_str_mv AT weiwei expressionofgpx4byoncolyticvacciniaviruscansignificantlyenhancecd8tcellfunctionanditsimpactagainstpancreaticductaladenocarcinoma
AT linqingtian expressionofgpx4byoncolyticvacciniaviruscansignificantlyenhancecd8tcellfunctionanditsimpactagainstpancreaticductaladenocarcinoma
AT xiaoyanzheng expressionofgpx4byoncolyticvacciniaviruscansignificantlyenhancecd8tcellfunctionanditsimpactagainstpancreaticductaladenocarcinoma
AT leizhong expressionofgpx4byoncolyticvacciniaviruscansignificantlyenhancecd8tcellfunctionanditsimpactagainstpancreaticductaladenocarcinoma
AT yuanchen expressionofgpx4byoncolyticvacciniaviruscansignificantlyenhancecd8tcellfunctionanditsimpactagainstpancreaticductaladenocarcinoma
AT huidong expressionofgpx4byoncolyticvacciniaviruscansignificantlyenhancecd8tcellfunctionanditsimpactagainstpancreaticductaladenocarcinoma
AT guibingzhang expressionofgpx4byoncolyticvacciniaviruscansignificantlyenhancecd8tcellfunctionanditsimpactagainstpancreaticductaladenocarcinoma
AT shibingwang expressionofgpx4byoncolyticvacciniaviruscansignificantlyenhancecd8tcellfunctionanditsimpactagainstpancreaticductaladenocarcinoma
AT xiangmintong expressionofgpx4byoncolyticvacciniaviruscansignificantlyenhancecd8tcellfunctionanditsimpactagainstpancreaticductaladenocarcinoma